BERNUZZI, FRANCESCA VERONICA
 Distribuzione geografica
Continente #
NA - Nord America 6.188
AS - Asia 2.729
EU - Europa 2.112
SA - Sud America 430
AF - Africa 90
Continente sconosciuto - Info sul continente non disponibili 7
OC - Oceania 1
Totale 11.557
Nazione #
US - Stati Uniti d'America 6.049
SG - Singapore 1.064
CN - Cina 570
HK - Hong Kong 383
SE - Svezia 377
RU - Federazione Russa 352
BR - Brasile 329
VN - Vietnam 300
DE - Germania 268
IT - Italia 263
IE - Irlanda 258
GB - Regno Unito 120
AT - Austria 106
UA - Ucraina 105
CA - Canada 101
FR - Francia 98
TR - Turchia 78
IN - India 62
FI - Finlandia 53
AR - Argentina 52
BD - Bangladesh 47
IQ - Iraq 32
ID - Indonesia 26
ZA - Sudafrica 26
DK - Danimarca 22
JP - Giappone 22
PK - Pakistan 21
MY - Malesia 20
MX - Messico 18
BE - Belgio 17
ES - Italia 16
DZ - Algeria 14
PH - Filippine 14
KR - Corea 13
NL - Olanda 13
MA - Marocco 11
CO - Colombia 10
SA - Arabia Saudita 10
KE - Kenya 9
PL - Polonia 9
TN - Tunisia 9
VE - Venezuela 9
EC - Ecuador 8
UZ - Uzbekistan 8
LT - Lituania 7
CL - Cile 6
IR - Iran 6
JO - Giordania 6
AL - Albania 5
EG - Egitto 5
JM - Giamaica 5
KZ - Kazakistan 5
LB - Libano 5
PY - Paraguay 5
AE - Emirati Arabi Uniti 4
AZ - Azerbaigian 4
CH - Svizzera 4
CR - Costa Rica 4
EU - Europa 4
NP - Nepal 4
OM - Oman 4
PE - Perù 4
RO - Romania 4
TH - Thailandia 4
A2 - ???statistics.table.value.countryCode.A2??? 3
BO - Bolivia 3
CZ - Repubblica Ceca 3
DO - Repubblica Dominicana 3
IL - Israele 3
MN - Mongolia 3
NG - Nigeria 3
PS - Palestinian Territory 3
UY - Uruguay 3
BH - Bahrain 2
BY - Bielorussia 2
CM - Camerun 2
GA - Gabon 2
HN - Honduras 2
MK - Macedonia 2
NO - Norvegia 2
RS - Serbia 2
SY - Repubblica araba siriana 2
TW - Taiwan 2
AU - Australia 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BW - Botswana 1
BZ - Belize 1
CV - Capo Verde 1
ET - Etiopia 1
GR - Grecia 1
GT - Guatemala 1
GY - Guiana 1
KH - Cambogia 1
LY - Libia 1
MM - Myanmar 1
NI - Nicaragua 1
PA - Panama 1
PR - Porto Rico 1
PT - Portogallo 1
Totale 11.551
Città #
Ann Arbor 696
Singapore 641
Fairfield 604
Woodbridge 556
Ashburn 525
Houston 397
Hong Kong 378
Chandler 335
Wilmington 291
Seattle 265
Dublin 250
San Jose 238
Dearborn 189
Cambridge 183
Frankfurt am Main 179
New York 143
Jacksonville 136
Santa Clara 114
Beijing 103
Princeton 102
Vienna 98
Ho Chi Minh City 97
Chicago 89
Milan 83
The Dalles 82
Nanjing 74
Hanoi 65
Lawrence 50
Los Angeles 50
Altamura 48
Lauterbourg 44
Shanghai 36
São Paulo 34
Lachine 32
Boardman 28
San Diego 27
Moscow 26
Council Bluffs 25
Dallas 25
Andover 24
Ottawa 24
Hefei 23
Nanchang 23
Buffalo 22
Tokyo 20
Toronto 19
Helsinki 17
Brussels 16
Penang 16
Johannesburg 14
Rio de Janeiro 14
Guangzhou 13
Hebei 13
Jakarta 13
Jinan 13
Norwalk 13
Nuremberg 13
Tianjin 13
Columbus 12
London 12
Montreal 12
Munich 12
Fremont 11
Orem 11
Salt Lake City 11
Changsha 10
Dhaka 10
Elk Grove Village 10
Hangzhou 10
Seoul 10
Shenyang 10
Baghdad 9
Boston 9
Dong Ket 9
Paris 9
San Mateo 9
Stockholm 9
Tampa 9
Zhengzhou 9
Brooklyn 8
Nairobi 8
Ankara 7
Atlanta 7
Hải Dương 7
Jiaxing 7
Leawood 7
Mountain View 7
Poplar 7
Rome 7
Belo Horizonte 6
Edmonton 6
Haiphong 6
Kunming 6
Lancaster 6
Lissone 6
Taizhou 6
Tashkent 6
Amsterdam 5
Brasília 5
Chennai 5
Totale 8.009
Nome #
Pretreatment prediction of response to ursodeoxycholic acid in primary biliary cholangitis: development and validation of the UDCA Response Score 568
A worldwide cross-ethnic study of quality of life in patients with PBC: Attitude or latitude? 423
Knockout of α-calcitonin gene-related peptide attenuates cholestatic liver injury by differentially regulating cellular senescence of hepatic stellate cells and cholangiocytes 335
Amelioration of Ductular Reaction by Stem Cell Derived Extracellular Vesicles in MDR2 Knockout Mice via Lethal-7 microRNA 324
Novel biomarkers for primary biliary cholangitis to improve diagnosis and understand underlying regulatory mechanisms 319
FRI-006-Soluble CD163 and mannose receptor as markers of liver disease severity and long term prognosis in patients with primary biliary cholangitis 279
From pathogenesis to novel therapies in the treatment of primary biliary cholangitis 276
Pathway-based analysis of primary biliary cirrhosis genome-wide association studies 273
The X-factor in primary biliary cirrhosis: Monosomy X and xenobiotics 267
miR-24 Inhibition Increases Menin Expression and Decreases Cholangiocarcinoma Proliferation 262
Inhibition of the apelin/apelin receptor axis decreases cholangiocarcinoma growth 253
Classical HLA-DRB1 and DPB1 alleles account for HLA associations with primary biliary cirrhosis 252
Ursodeoxycholate inhibits mast cell activation and reverses biliary injury and fibrosis in Mdr2−/− mice and human primary sclerosing cholangitis 247
International genome-wide meta-analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathways 246
Immunochip analyses identify a novel risk locus for primary biliary cirrhosis at 13q14, multiple independent associations at four established risk loci and epistasis between 1p31 and 7q32 risk variants. 237
Neuropeptide Y inhibits cholangiocarcinoma cell growth and invasion 235
Increased local dopamine secretion has growth-promoting effects in cholangiocarcinoma 234
Serotonin metabolism is dysregulated in cholangiocarcinoma, which has implications for tumor growth 231
Phenotypical and functional alterations of CD8 regulatory T cells in primary biliary cirrhosis 230
Nicotine Promotes Cholangiocarcinoma Growth in Xenograft Mice 225
Melatonin exerts by an autocrine loop antiproliferative effects in cholangiocarcinoma; its synthesis is reduced favoring cholangiocarcinoma growth 223
Autoantibodies in patients with interleukin 12 receptor beta 1 deficiency 220
Knockdown of Hepatic Gonadotropin-Releasing Hormone by Vivo-Morpholino Decreases Liver Fibrosis in Multidrug Resistance Gene 2 Knockout Mice by Down-Regulation of miR-200b 218
Blocking H1/H2 histamine receptors inhibits damage/fibrosis in Mdr2–/– mice and human cholangiocarcinoma tumorigenesis 218
MicroRNAs in autoimmunity and inflammatory bowel disease: Crucial regulators in immune response 217
Genome-wide meta-analyses identify three loci associated with primary biliary cirrhosis 216
Soluble CD163 and mannose receptor as markers of liver disease severity and prognosis in patients with primary biliary cholangitis 215
Interleukin-6-driven progranulin expression increases cholangiocarcinoma growth by an Akt-dependent mechanism 210
Comprehensive review of autoantibodies in patients with hyper-IgM syndrome 210
Prolonged darkness reduces liver fibrosis in a mouse model of primary sclerosing cholangitis by miR-200b down-regulation 209
A precious metal: Iron, an essential nutrient for all cells 208
Inhibition of mast cell-secreted histamine decreases biliary proliferation and fibrosis in primary sclerosing cholangitis Mdr2−/− mice 208
Immunoglobulin M levels inversely correlate with CD40 ligand promoter methylation in patients with primary biliary cirrhosis 207
Inhibition of microRNA-24 increases liver fibrosis by enhanced menin expression in Mdr2−/− mice 205
Strong iron demand during hypoxia-induced erythropoiesis is associated with down-regulation of iron-related proteins and myoglobin in human skeletal muscle 204
Reactive oxygen species-independent apoptosis in doxorubicin-treated H9c2 cardiomyocytes: Role for heme oxygenase-1 down-modulation 204
Forkhead box A2 regulates biliary heterogeneity and senescence during cholestatic liver injury in mice‡ 203
The secretin/secretin receptor axis modulates liver fibrosis through changes in transforming growth factor-β1 biliary secretion in mice 200
Th17 and regulatory T lymphocytes in primary biliary cirrhosis and systemic sclerosis as models of autoimmune fibrotic diseases 198
Identification of serum and tissue micro-RNA expression profiles in different stages of inflammatory bowel disease 197
Telomere dysfunction in peripheral blood mononuclear cells from patients with primary biliary cirrhosis 197
Human leukocyte antigen polymorphisms in Italian primary biliary cirrhosis: A multicenter study of 664 patients and 1992 healthy controls 196
Serum microRNAs as novel biomarkers for primary sclerosing cholangitis and cholangiocarcinoma 189
Knockout of microRNA-21 reduces biliary hyperplasia and liver fibrosis in cholestatic bile duct ligated mice 187
TNF-α polymorphisms in primary biliary cirrhosis: A Northern and Southern Italian experience 186
DNA methylation profiling of the X chromosome reveals an aberrant demethylation on CXCR3 promoter in primary biliary cirrhosis 185
Therapeutic potential of IL-17-mediated signaling pathway in autoimmune liver diseases 185
Lack of Siglec-7 expression identifies a dysfunctional natural killer cell subset associated with liver inflammation and fibrosis in chronic HCV infection 181
Secretin/secretin receptor signaling mediates biliary damage and liver fibrosis in early-stage primary biliary cholangitis 164
Cytokines in the Liver: Cytokine Mechanisms in Liver Health and Disease 138
Substance P increases liver fibrosis by differential changes in senescence of cholangiocytes and hepatic stellate cells 116
Soluble CD163 and mannose receptor as markers of liver disease severity and long term prognosis in patients with primary biliary cholangitis 108
Totale 11.938
Categoria #
all - tutte 38.728
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 38.728


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021252 0 0 0 0 0 0 0 0 0 104 79 69
2021/2022711 71 63 127 66 26 46 31 41 26 37 73 104
2022/20231.171 104 346 89 126 77 185 21 69 104 3 31 16
2023/2024739 23 24 6 60 93 204 146 46 44 11 5 77
2024/20251.584 92 145 130 87 153 42 77 58 167 284 109 240
2025/20263.177 351 193 270 317 477 230 474 211 348 306 0 0
Totale 11.938